<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04893460</url>
  </required_header>
  <id_info>
    <org_study_id>NIH 1 R43DP006495-01-00</org_study_id>
    <nct_id>NCT04893460</nct_id>
  </id_info>
  <brief_title>CoQuit Study for Smoking Cessation</brief_title>
  <official_title>A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Research Behavioral Intervention Strategies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Research Behavioral Intervention Strategies, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the feasibility of a cognitive dissonance-based mobile app for&#xD;
      smoking cessation (CDI). Cognitive dissonance refers to the conflict between beliefs and&#xD;
      behaviors; interventions are designed to promote this conflict to motivate people to change&#xD;
      their behavior. Recent research has demonstrated the efficacy and potential of using&#xD;
      cognitive dissonance interventions for a wide range of health and behavioral problems&#xD;
      including smoking cessation. This study will develop an initial version of the CDI mobile app&#xD;
      and evaluate the app in an evaluation study with 60 adult smokers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A group of 60 adult smokers will use and evaluate the initial version of the CoQuit app. All&#xD;
      participants will be recruited through social media; they will be screened and consented&#xD;
      online. After enrolling, participants will receive a link to the baseline survey which asks&#xD;
      about past and current tobacco use, nicotine dependence, motivation to quit, cognitive&#xD;
      dissonance and demographic information. All participants will then be assigned to an online&#xD;
      support group of 5 or 6 people. The group will receive simultaneous invites to the app so&#xD;
      they can move through the 25 day program together. The app contains short videos of a CoQuit&#xD;
      facilitator who presents instructions for specific tasks, such as writing a brief letter to a&#xD;
      friend or family member explaining the decision to stop smoking. Participants will make&#xD;
      videos of themselves related to these activities and post the videos within the app where&#xD;
      they can be viewed by other members of the group. All participants will complete a six weeks&#xD;
      post baseline online assessment asking about past and current tobacco use, quit attempts, and&#xD;
      thoughts about navigation, ease of program use, and possible improvements to the app.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Actual">September 29, 2021</completion_date>
  <primary_completion_date type="Actual">September 29, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tobacco Abstinence</measure>
    <time_frame>Six weeks post baseline</time_frame>
    <description>Self report of quitting tobacco use</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Attempts to Quit Smoking</measure>
    <time_frame>Six weeks post baseline</time_frame>
    <description>Self report of successful attempts to not smoke for 24 hours or more</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will use the CoQuit App for Smoking Cessation</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CoQuit App</intervention_name>
    <description>The CoQuit App is a cognitive dissonance based app for smoking cessation.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Self-reported daily smoking&#xD;
&#xD;
          -  Having a valid home mailing address&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  Access to a smartphone with video capability and internet&#xD;
&#xD;
          -  Not currently participating in any tobacco cessation programs&#xD;
&#xD;
          -  Expressed desire to quit smoking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Smith, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Influents Innovations/Oregon Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Herb Severson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Influents Innovations/Oregon Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ORBIS/Oregon Research Institute</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 14, 2021</study_first_submitted>
  <study_first_submitted_qc>May 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2021</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

